6 Top Oil and Gas Stocks Analysts Want You to Buy
The week of September 12 brought a fair number analyst upgrades and downgrades in oil and gas stocks. Some analysts believe many of the energy stocks continue to be very smart buys, based on…
The week of September 12 brought a fair number analyst upgrades and downgrades in oil and gas stocks. Some analysts believe many of the energy stocks continue to be very smart buys, based on…
Intel shares saw a handy gain to close out the week after the company raised guidance for its third quarter, due to replenishment of PC supply chain inventory.
Novavax was pummeled by shareholders on Friday after the company reported top-line results from its RSV F Vaccine trials.
VimpelCom intends to offer more than 142 million shares at $3.50 apiece, in a secondary offering valued up to more than $573 million.
After Oracle reported its fiscal first-quarter financial results after the markets closed on Thursday, this networking giant's shares slipped in the after-hours session.
Shares of AcelRx Pharmaceuticals Inc. (NASDAQ: ACRX) surged following positive results from a late-stage trial. The company announced the outcome of an open-label Phase 3 trial (SAP303) of investigational product candidate ARX-04. Let us just say, it…
Caladrius Biosciences watched its shares soar on Thursday after the company announced a private placement offering.
Jefferies reiterated its price target on AT&T, noting the ways in which the company is well-positioned to meet future demands.
The attention around the upcoming release of the iPhone 7 is making analysts think that this could be a better than expected iPhone cycle in both volume in mix.
Goodyear Tire & Rubber has announced its updated financial performance targets and a solid dividend hike, as increasing demand for larger, more profitable tires has boosted the business.
The Philly Fed Survey signaled that manufacturing conditions continued to improve, with positive indicators for general activity and new orders increasing from their August numbers.
Shares of Aeri Pharmaceuticals skyrocketed early Thursday after the company issued positive results on its intraocular pressure (IOP) treatment in patients with glaucoma.
Sarepta Therapeutics closed out Wednesday with its shares up over 25% following positive developments surrounding eteplirsen, its treatment of Duchenne muscular dystrophy.
Oracle Corp. (NYSE: ORCL) is scheduled to report its fiscal first-quarter financial results after markets close on Thursday. The consensus estimates from Thomson Reuters are calling for $0.58 in earnings per share (EPS) and…
Jeld-Wen Holding has amended its filing with the U.S. Securities and Exchange Commission (SEC) regarding its initial public offering (IPO).
Carl Icahn believes that Herbalife might be better off as a privately held firm and he has weighed the possibility of launching a tender offer for it.
Cracker Barrel Old Country Store released disappointing fiscal fourth-quarter financial results before the markets opened on Wednesday.
At Home Group reported its fiscal second-quarter financial results after the markets closed on Tuesday, and shares rallied early Wednesay.
Agios Pharmaceuticals has filed with the SEC regarding a secondary offering of up to $150 million of its common stock.
The goal of Allergan’s bid for Vitae Pharmaceuticals is to bolster its dermatology product pipeline, and Vitae shareholders appear happy to oblige.